Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00629148 | Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00601159 | Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | completed | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT01206881 |
| Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer |
| completed |
| Phase 2 |
| 45 |
| Herlev HospitalOTHER |
| 1 |
| Jul 4, 2011 |
| clinicaltrials |
| NCT01053468 | Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy(PROACTIVE) | unknown | Phase 2 | 150 | Athabasca UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00524810 | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 67 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00532272 | Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | completed | Phase 2 | 78 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00532623 | Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 82 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00532285 | Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer | terminated | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00651417 | Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue | unknown | Phase 2 | 101 | Arizona Oncology ServicesOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00004085 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00976365 | Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer | completed | Phase 2 | 60 | Taiwan THL Co.LTd.INDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT01199354 | Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC)(M-RIC) | unknown | Phase 2 | 80 | Clinique ClementvilleOTHER | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00101062 | Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | — | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00110084 | ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Jun 2, 2011 | clinicaltrials |
| NCT00031278 | Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 12 | PfizerINDUSTRY | 1 | May 30, 2011 | clinicaltrials |
| NCT01352494 | Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer(NeoTG) | unknown | Phase 2 | 99 | Korean Breast Cancer Study GroupOTHER | 1 | May 27, 2011 | clinicaltrials |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | completed | Phase 2 | 135 | Eli Lilly and CompanyINDUSTRY | 5 | May 20, 2011 | clinicaltrials |
| NCT00790894 | Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)(HIT) | terminated | Phase 2 | 64 | Hellenic Cooperative Oncology GroupOTHER | 1 | May 18, 2011 | clinicaltrials |
| NCT00645866 | Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 2 | 47 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00771433 | G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 2 | 120 | Centre Francois BaclesseOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT01351597 | A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer(STORM) | unknown | Phase 2 | 51 | Korean Breast Cancer Study GroupOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00193024 | Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer | terminated | Phase 2 | 90 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00193076 | Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer | completed | Phase 2 | 96 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00193102 | Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer | terminated | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00497809 | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | completed | Phase 2 | 189 | AviGenicsINDUSTRY | 2 | May 3, 2011 | clinicaltrials |
| NCT00216073 | Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer | terminated | Phase 2 | 11 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00522457 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy | terminated | Phase 2 | 19 | Neovii BiotechINDUSTRY | 2 | Apr 29, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00253539 | Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer | completed | Phase 2 | 3 | The Cleveland ClinicOTHER | 0 | Apr 13, 2011 | clinicaltrials |
| NCT00496288 | Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer | unknown | Phase 2 | 240 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Apr 5, 2011 | clinicaltrials |
| NCT00006825 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003035 | Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 40 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00967824 | Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer | completed | Phase 1 / Phase 2 | 1,683 | University of Michigan Rogel Cancer CenterOTHER | 0 | Mar 24, 2011 | clinicaltrials |
| NCT01112189 | Use of Stem Cells in Lymphedema Post Mastectomy(SCL) | completed | Phase 1 / Phase 2 | 20 | Hospital Universitario Dr. Jose E. GonzalezOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT01321775 | Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer | unknown | Phase 2 | 44 | Hospital Universitario Madrid SanchinarroOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00186524 | Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer? | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | Mar 15, 2011 | clinicaltrials |
| NCT00371254 | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer | completed | Phase 2 | 55 | Bristol-Myers SquibbINDUSTRY | 4 | Mar 15, 2011 | clinicaltrials |
| NCT00003877 | Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00270491 | Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. | completed | Phase 2 | 130 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00879489 | Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 24 | Quantum Immunologics, Inc.OTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00263705 | Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study | completed | Phase 2 | 43 | Jules Bordet InstituteOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT00028964 | Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer | completed | Phase 1 / Phase 2 | — | University of California, San FranciscoOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00316407 | Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Swedish Medical CenterOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT00252811 | A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer | withdrawn | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00239343 | Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer | completed | Phase 2 | 160 | AstraZenecaINDUSTRY | 3 | Jan 27, 2011 | clinicaltrials |
| NCT00930475 | Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 54 | Charite University, Berlin, GermanyOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00322348 | Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women | completed | Phase 2 | 98 | AstraZenecaINDUSTRY | 3 | Jan 24, 2011 | clinicaltrials |
| NCT00235937 | Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex | completed | Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jul 7, 2011source: clinicaltrials